LEONI, ALESSANDRO
 Distribuzione geografica
Continente #
AS - Asia 1.346
NA - Nord America 1.345
EU - Europa 1.026
SA - Sud America 190
AF - Africa 48
OC - Oceania 5
Totale 3.960
Nazione #
US - Stati Uniti d'America 1.284
IT - Italia 542
SG - Singapore 521
CN - Cina 265
BD - Bangladesh 158
BR - Brasile 149
HK - Hong Kong 128
DE - Germania 119
VN - Vietnam 90
FR - Francia 74
FI - Finlandia 52
GB - Regno Unito 50
IN - India 42
RU - Federazione Russa 35
CA - Canada 29
TR - Turchia 29
NL - Olanda 25
PL - Polonia 23
MX - Messico 22
CZ - Repubblica Ceca 21
ZA - Sudafrica 20
ES - Italia 17
JP - Giappone 16
IQ - Iraq 12
AR - Argentina 11
IE - Irlanda 11
SE - Svezia 11
TH - Thailandia 10
AT - Austria 9
ID - Indonesia 9
UA - Ucraina 9
CH - Svizzera 8
CO - Colombia 8
EG - Egitto 8
MA - Marocco 8
IR - Iran 7
AE - Emirati Arabi Uniti 5
AU - Australia 5
BE - Belgio 5
EC - Ecuador 5
OM - Oman 5
SA - Arabia Saudita 5
TW - Taiwan 5
DZ - Algeria 4
LK - Sri Lanka 4
NP - Nepal 4
PH - Filippine 4
VE - Venezuela 4
CL - Cile 3
ET - Etiopia 3
GR - Grecia 3
KR - Corea 3
MY - Malesia 3
PE - Perù 3
PS - Palestinian Territory 3
PT - Portogallo 3
PY - Paraguay 3
UY - Uruguay 3
UZ - Uzbekistan 3
AL - Albania 2
AZ - Azerbaigian 2
CR - Costa Rica 2
IL - Israele 2
KE - Kenya 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LT - Lituania 2
PA - Panama 2
PK - Pakistan 2
SN - Senegal 2
AM - Armenia 1
BO - Bolivia 1
BZ - Belize 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
JM - Giamaica 1
JO - Giordania 1
LB - Libano 1
NI - Nicaragua 1
RO - Romania 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 3.960
Città #
Singapore 310
Ashburn 181
San Jose 178
Hong Kong 127
New York 102
Brescia 79
Los Angeles 69
Munich 63
Dallas 61
Milan 59
Beijing 54
The Dalles 42
Council Bluffs 36
Rome 33
Des Moines 32
Lauterbourg 32
Helsinki 29
Chandler 27
Ho Chi Minh City 26
Boardman 25
Santa Clara 25
Hanoi 24
Istanbul 20
São Paulo 20
Frankfurt am Main 18
San Francisco 18
Buffalo 17
Shanghai 17
Turku 17
Brno 15
Redondo Beach 15
Seattle 15
Tokyo 15
Turin 15
Chicago 14
Orem 14
London 13
Warsaw 13
Barlassina 12
Johannesburg 12
Mexico City 12
Nuremberg 12
Boston 11
Toronto 11
Dublin 10
Poplar 10
Wroclaw 10
Romola 9
Stockholm 9
Verona 9
Atlanta 8
Brooklyn 8
Chennai 8
Moscow 8
Bangkok 7
Bovegno 7
Charlotte 7
Mumbai 7
Zurich 7
Bologna 6
Denver 6
Fairfield 6
Florence 6
Houston 6
Manchester 6
Paris 6
Princeton 6
Baghdad 5
Cairo 5
Düsseldorf 5
Lappeenranta 5
Montreal 5
Olomouc 5
Palermo 5
Parma 5
Pune 5
Tianjin 5
Brussels 4
Colombo 4
Cremona 4
Da Nang 4
Hải Dương 4
Jakarta 4
Maple Grove 4
Modena 4
Pescara 4
Phoenix 4
Poncarale 4
Sommacampagna 4
Sulaymaniyah 4
Addis Ababa 3
Ancona 3
Bari 3
Belo Horizonte 3
Brasília 3
Buenos Aires 3
Calgary 3
Cape Town 3
Curitiba 3
Elk Grove Village 3
Totale 2.244
Nome #
Feasibility Study on detection and monitoring of gene-mutations by digital (dPCR) NGS driven in patients with Acute Myeloid Leukemias (AMLs) and High-Risk Myelodysplastic Syndromes (HR-MDSs)- “dPCR-NGS Driven Study” 205
Evaluation of Circulating Endothelial Cells as Direct Marker of Endothelial Damage in Allo-Transplant Recipients at High Risk of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome 167
High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: A case report and literature review 158
CT-290: Clinical Frailty Scale as a Novel Tool to Evaluate Patients’ Eligibility for Allogeneic Stem Cell Transplant: A Single-Center Experience on 234 Patients >50 Years Old 146
Different In Vitro Models of Chronic Myeloid Leukemia Show Different Characteristics: Biological Replicates Are Not Biologically Equivalent 145
Venetoclax plus decitabine as a bridge to allogeneic haematopoietic stem-cell transplantation in older patients with acute myeloid leukaemia (VEN-DEC GITMO): final report of a multicentre, single-arm, phase 2 trial 145
Is the New Tci Score Sufficient to Categorize the Intensity of Conditioning? a Single-Centre Study 136
PB2209: HIGH RISK MYELODYSPLASTIC SYNDROME DEVELOPING IN A PATIENT AFTER CHIMERIC ANTIGEN RECEPTOR (CAR) T- CELL THERAPY FOR RELAPSED DIFFUSE LARGE B CELL LYMPHOMA 130
Bone marrow CD34+ molecular chimerism as an early predictor of relapse after allogeneic stem cell transplantation in patients with acute myeloid leukemia 129
P1450: AUTOLOGOUS STEM CELL TRANSPLANTATION INDUCES HIGHER LEVEL OF EXHAUSTED T-CELLS IN DLBCL PATIENTS BEFORE LEUKAPHERESIS FOR CAR-T CELL THERAPY 128
Autologous Stem Cell Transplantation before Lymphocyte Apheresis for CAR-T Cells Therapy Negatively Impacts on T-Cells Fitness and NK Cell Levels in DLBCL Patients 124
Changes in Stem Cell Transplant activity and procedures during SARS-CoV2 pandemic in Italy: an Italian Bone Marrow Transplant Group (GITMO) nationwide analysis (TransCOVID-19 Survey) 122
Feasibility of Leukemia-Derived Exosome Enrichment and Co-isolated dsDNA Sequencing in Acute Myeloid Leukemia Patients: A Proof of Concept for New Leukemia Biomarkers Detection 121
Nutritional intervention with TGF-beta enriched food for special medical purposes (TGF-FSMP) is associated with a reduction of malnutrition, acute GVHD, pneumonia and may improve overall survival in patients undergoing allogeneic hematopoietic stem transplantation 120
Potentiality of Bone Marrow-Derived Mesenchymal Stromal Cells (BM-MSCs) to Differentiate into the Osteogenic Lineage in in Vitro Model of Tissue Regeneration 107
Correlation between BCR::ABL1 Transcript LEVEL in Circulating Extracellular Vesicles and BOTH the Molecular Response and the Ongoing Therapy: A Study on Adult CML Patients 106
Timely Leukapheresis May Interfere with the “Fitness” of Lymphocytes Collected for CAR-T Treatment in High Risk DLBCL Patients 105
Malnutrition Prevention after Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT): A Prospective Explorative Interventional Study with an Oral Polymeric Formulation Enriched with Transforming Growth Factor Beta 2 (TGF-β2) 102
Evaluation of Circulating Endothelial Cells (CECs) As Marker of Endothelial Damage in Allo-Transplanted Patients at High Risk of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS): The Cecinvod Study 101
Successful CAR-T cell therapy in a refractory MCL patient with bacterial, fungal and COVID-19 infection: a case report 100
CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation 97
Secondary Myeloid Neoplasms after CD19 CAR-T Cell Therapy: Real-Life Multicenter Data from the Clonhema Study 95
Immune Reconstitution after Allogenic Stem Cell Transplantation in Patients with Myelofibrosis 95
How We Manage Myelofibrosis Candidates for Allogeneic Stem Cell Transplantation 94
Donor Lymphocyte Infusion in the Treatment of Post-Transplant Relapse of Acute Myeloid Leukemias and Myelodysplastic Syndromes Significantly Improves Overall Survival: A French–Italian Experience of 134 Patients 93
PB1959: BCR::ABL1 TRANSCRIPT IN SMALL EXTRACELLULAR VESICLES ISOLATED IN ADULT CHRONIC MYELOID LEUKEMIA PATIENTS CORRELATES WITH MOLECULAR RESPONSE LEVEL AND THE ONGOING THERAPY 93
The Applications of Machine Learning in the Management of Patients Undergoing Stem Cell Transplantation: Are We Ready? 88
Digital PCR (dPCR) is able to anticipate the achievement of stable deep molecular response in adult chronic myeloid leukemia patients: results of the DEMONSTRATE study 78
Correction: CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation (Bone Marrow Transplantation, (2023), 10.1038/s41409-023-02124-y) 78
Real-world outcomes of total body irradiation-based conditioning in allogeneic hematopoietic stem cell transplantation: A single-center retrospective study 74
Isolated Cerebral Myeloid Sarcoma in an Allogeneic Stem Cell Transplant Recipient 73
Assessment of Chronic Myeloid Leukaemia In Vitro Models Variability: Insights Into Extracellular Vesicles 70
Real-world collection of secondary myeloid neoplasms after CD19 CAR-T cell therapy: first report of the ClonHema study 59
Stimulated CAR-T cells from non-Hodgkin lymphomas patients engage and activate monocytes via extracellular vesicles 34
Beyond presence: Clinical relevance of FLT3-ITD length and location in Acute Myeloid Leukemia (AML) 33
Psychosocial well-being in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT) and their caregivers: A prospective study 33
P022 | Fourier-transform infrared spectroscopy analysis of plasma-derived extracellular vesicles as a tool to detect TKI-related toxicity in chronic myeloid leukemia patients: a preliminary study 31
P046 | Beyond the mutation: prognostic role of FLT3-ITD length and genomic context in acute myeloid leukemia 30
CO41 | Monocyte activation by CAR-T cells: role of extracellular vesicles and secretome in immune modulation 30
Tracking leukemic residuals: dissecting the inverse relationship between CD26+ stem cells and extracellular BCR::ABL1 transcript in Chronic Myeloid Leukemia (CML) 28
Transcriptomic analysis of CD34⁺ cells in myelofibrosis highlights their role in extracellular matrix dysregulation and marrow fibrosis 24
P044 | From cells to vesicles: next-generation measurable residual disease tracking in acute myeloid leukemia with NGS and digital PCR 23
CO43 | Fourier-transform infrared spectroscopy of plasma as a liquid biopsy for monitoring acute myeloid leukemia and extramedullary relapse following allo-HSCT 21
CO61 | Transcriptomic analysis of CD34⁺ cells in myelofibrosis highlights their role in extracellular matrix dysregulation and marrow fibrosis 16
P026 | Tracking residual chronic myeloid leukemia: complementary insights from CD26⁺ stem cells and extracellular BCR::ABL1 14
NGS-Driven Digital PCR for Personalized and Accurate Measurable Residual Disease Assessment in Acute Myeloid Leukemia 8
Totale 4.009
Categoria #
all - tutte 17.560
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.560


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214 0 0 0 0 0 0 0 0 0 0 0 4
2021/202241 0 0 2 0 0 0 5 10 3 9 3 9
2022/2023132 4 1 8 23 8 26 0 12 14 4 16 16
2023/2024284 5 7 16 16 28 49 17 17 39 10 8 72
2024/2025932 8 28 25 72 57 61 72 44 164 105 166 130
2025/20262.613 138 176 150 281 251 241 364 130 224 269 203 186
Totale 4.009